Fig. 3From: Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case reportStructure prediction of ETF:QO. The predicted wild-type model of human ETF:QO with Ala84 and Tyr257 in the hydrophobic FAD-binding domain shown in ball-and-stick representationsBack to article page